PedAM
Pediatric Disease Annotations & Medicines
| Disease | mental depression |
| Phenotype | C0242379|lung cancer |
| Sentences | 18 |
| PubMedID- 23102652 | We therefore conducted a systematic review of relevant randomised controlled trials to determine which, if any, treatments have been found to be effective for depression in patients with lung cancer. |
| PubMedID- 25800229 | The impact of a multidimensional exercise intervention on physical and functional capacity, anxiety, and depression in patients with advanced-stage lung cancer undergoing chemotherapy. |
| PubMedID- 26516360 | Purpose: the current study examined quality of life, progression of disease, and survival rate during chemotherapy in newly diagnosed non-small cell lung cancer (nsclc) patients with depression (n=48) and without depression (n=78). |
| PubMedID- 23680580 | Methods: using a modified adapte process, panels of local experts adapted national guidelines and integrated research evidence to create computable algorithms with explicit recommendations for management of the most common symptoms (pain, fatigue, dyspnea, depression, and anxiety) associated with lung cancer. |
| PubMedID- 25316948 | depression in lung cancer patients. |
| PubMedID- 22473594 | Background: various risk factors for depression in lung cancer patients have been suggested but have been examined separately in studies with relatively small sample sizes. |
| PubMedID- 25175097 | We aimed to assess the efficacy of an integrated treatment programme for major depression in patients with lung cancer compared with usual care. |
| PubMedID- 23794580 | Fatigue and ‘disabilities’ independently predicted depression among patients with lung cancer starting treatment26 and have been observed in prechemotherapy patients with curative cancer.27 a high-symptom burden can persist over time. |
| PubMedID- PMC3287701 | Smart oncology-3 is a 150 patient efficacy trial evaluating a similar intervention for depression in patients with lung cancer, who have limited life expectancy, with data collected over eight months to give an average depression score for the primary outcome. |
| PubMedID- 21807767 | In the present study, we explored the degree to which tumor genotype may be associated with depression in patients with non-small cell lung cancer (nsclc). |
| PubMedID- 23969030 | The diurnal rhythms of sputum il-6, sputum tnf-alpha and salivary cortisol were measured in lung cancer patients with and without depression as well as depressed controls and healthy controls. |
| PubMedID- 22383265 | depression in lung cancer patients: the role of perceived stigma. |
| PubMedID- 23731354 | Our aim was to asses if dimensions of temperament and character could predict depression in lung cancer patients. |
| PubMedID- 22095232 | Several small- and medium-scale studies on this topic exist and have for example revealed particularly high levels of depression in patients with lung cancer (hopwood and stephens, 2000; néron et al, 2007; castelli et al, 2009), but comparison studies with sufficient statistical power to examine various potential predictor and moderator variables are scarce. |
| PubMedID- 22510506 | Conclusions: feiji decoction for soothing the liver combined with psychotherapy can alleviate depression and anxiety in patients with primary lung cancer. |
| PubMedID- 26360998 | The prevalence of major depression was highest in patients with lung cancer (13.1%, 95% ci 11.9-14.2%), followed by gynaecological cancer (10.9%, 9.8-12.1), breast cancer (9.3%, 8.7-10.0), colorectal cancer (7.0%, 6.1-8.0), and genitourinary cancer (5.6%, 4.5-6.7). |
| PubMedID- 26273380 | Self-reported depression among patients with non-small cell lung cancer. |
| PubMedID- 23967823 | However, due to a few of studies (the number is less than or equal to 3) separately reporting the or for depression and anxiety in patients with breast cancer, lung cancer, liver cancer, the subgroup comparison of depression and anxiety in different types of cancer patients were not analyzed. |
Page: 1